Oppenheimer Sticks to Their Buy Rating for Aclaris Therapeutics (ACRS)
at www.tipranks.com (Fri, 6-Nov 9:58 AM)
Aclaris Therapeutics (ACRS) Gets a Buy from Canaccord Genuity
at www.tipranks.com (Fri, 6-Nov 9:53 AM)
Aclaris Therapeutics GAAP EPS of -$0.12 beats by $0.04, revenue of $1.48M beats by $0.25M
at seekingalpha.com (Thu, 5-Nov 7:22 AM)
